Clinical Applications of High-Flow Nasal Cannula during Intubation and Weaning from Mechanical Ventilation

2021 ◽  
pp. 81-99
Author(s):  
Mariangela Battilana ◽  
Luca Serano ◽  
Carmine Giovanni Iovino ◽  
Pierluigi Di Giannatale ◽  
Ivan Dell’Atti ◽  
...  
Keyword(s):  
Mechanical Ventilation ◽  
Clinical Applications ◽  
High Flow ◽  
Nasal Cannula ◽  
Weaning From Mechanical Ventilation ◽  
High Flow Nasal Cannula

scholarly journals A pediatric case managed with high-flow nasal cannula oxygen during weaning from mechanical ventilation

2014 ◽  
Vol 21 (3) ◽  
pp. 285-286
Author(s):  
Shinya Miura ◽  
Tatsuya Kawasaki ◽  
Ikuya Ueta ◽  
Takuma Kishimoto ◽  
Yusuke Itou ◽  
...  
Keyword(s):  
Mechanical Ventilation ◽  
High Flow ◽  
Nasal Cannula ◽  
Weaning From Mechanical Ventilation ◽  
High Flow Nasal Cannula ◽  
Pediatric Case

Use of High-Flow Nasal Cannula in Patients With Pneumonia and Hypoxemic Respiratory Failure at Altitudes Above 2600 m: What Is the Best Predictor of Success?

2021 ◽  
pp. 088506662110575
Author(s):  
Molano Franco Daniel ◽  
Gómez Duque Mario ◽  
Beltrán Edgar ◽  
Villabon Mario ◽  
Hurtado Alejandra ◽  
...  
Keyword(s):  
Mechanical Ventilation ◽  
Respiratory Failure ◽  
Respiratory Rate ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula ◽  
Multicenter Cohort Study ◽  
Hypoxemic Respiratory Failure ◽  
Severity Scores ◽  
High Flow Oxygen

Introduction: The use of high-flow nasal cannulas (HFNC) in patients with hypoxemic ventilatory failure reduces the need for mechanical ventilation and does not increase mortality when intubation is promptly applied. The aim of the study is to describe the behavior of HFNC in patients who live at high altitudes, and the performance of predictors of success/failure of this strategy. Methods: Prospective multicenter cohort study, with patients aged over 18 years recruited for 12 months in 2020 to 21. All had a diagnosis of hypoxemic respiratory failure secondary to pneumonia, were admitted to intensive care units, and were receiving initial management with a high-flow nasal cannula. The variables assessed included need for intubation, mortality in ICU, and the validation of SaO2, respiratory rate (RR) and ROX index (IROX) as predictors of HFNC success / failure. Results: One hundred and six patients were recruited, with a mean age of 59 years and a success rate of 74.5%. Patients with treatment failure were more likely to be obese (BMI 27.2 vs 25.5; OR: 1.03; 95% CI: .95-1.1) and had higher severity scores at admission (APACHE II 12 vs 20; OR 1.15; 95% CI: 1.06-1.24). Respiratory rates after 12 (AUC .81 CI: .70-.92) and 18 h (AUC .85 CI: .72-0.90) of HFNC use were the best predictors of failure, performing better than those that included oxygenation. ICU mortality was higher in the failure group (6% vs 29%; OR 8.8; 95% CI:1.75-44.7). Conclusions: High-flow oxygen cannula therapy in patients with hypoxemic respiratory failure living at altitudes above 2600 m is associated with low rates of therapy failure and a reduced need for mechanical ventilation in the ICU. The geographical conditions and secondary physiological changes influence the performance of the traditionally validated predictors of therapy success. Respiratory rate <30 proved to be the best indicator of early success of the device at 12 h of use.

FLOR Index to Predict the Need of Mechanical Ventilation in Patients With Pneumonia Treated With High Flow Nasal Cannula

CHEST Journal ◽  
2014 ◽  
Vol 145 (3) ◽  
pp. 180A
Author(s):  
Berta Caralt Ramisa ◽  
Oriol Roca ◽  
Joan Ramon Masclans ◽  
Marina García de Acilu ◽  
Jordi Rello
Keyword(s):  
Mechanical Ventilation ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula
Sign in / Sign up

Export Citation Format

Share Document